Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 188 entries
View as:

Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00349102 Org: User:
Start: 07/31/06 End: 01/31/14 Due: 01/31/15

Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type

Phase: N/A Priority: Normal
NCT ID: NCT03714958 Org: User:
Start: 12/20/18 End: 09/12/23 Due: 09/12/24

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Phase: N/A Priority: Normal
NCT ID: NCT05096390 Org: User:
Start: 06/01/22 End: 06/30/26 Due: 06/30/27

PREventing Second Cancers With DOSTARlimab

Phase: N/A Priority: Normal
NCT ID: NCT05855811 Org: User:
Start: 07/26/23 End: 03/26/29 Due: 03/26/30

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03474094 Org: User:
Start: 08/01/18 End: 08/01/24 Due: 08/01/25

Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT02977156 Org: User:
Start: 01/03/17 End: 06/06/22 Due: 06/06/23

Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT02728167 Org: User:
Start: 04/30/16 End: 08/31/18 Due: 08/31/19

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01202032 Org: User:
Start: 07/31/10 End: 03/31/13 Due: 03/31/14

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04011982 Org: User:
Start: 09/01/20 End: 04/30/28 Due: 04/30/29

Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06692556 Org: User:
Start: 12/31/24 End: 06/30/29 Due: 06/30/30

Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT03818061 Org: User:
Start: 03/26/19 End: 03/01/24 Due: 03/01/25

Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01066741 Org: User:
Start: 05/31/09 End: 08/31/11 Due: 08/31/12

Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay

Phase: N/A Priority: Normal
NCT ID: NCT02797405 Org: User:
Start: 10/31/16 End: 03/13/20 Due: 03/13/21

The βIG-H3 Protein: a New Marker in PANCreatic Adenocarcinoma (BIGHPANC)

Phase: N/A Priority: Normal
NCT ID: NCT03472716 Org: User:
Start: 05/22/18 End: 09/30/23 Due: 09/30/24

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Phase: N/A Priority: Normal
NCT ID: NCT02008019 Org: User:
Start: 08/14/14 End: 08/31/19 Due: 08/31/20

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01466868 Org: User:
Start: 11/30/11 End: 06/30/14 Due: 06/30/15

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04216953 Org: User:
Start: 02/12/20 End: 02/01/27 Due: 02/01/28

BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT03628859 Org: User:
Start: 12/21/18 End: 12/31/23 Due: 12/31/24

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT03723967 Org: User:
Start: 05/16/19 End: 03/09/24 Due: 03/09/25

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01774409 Org: User:
Start: 02/28/13 End: 07/31/26 Due: 07/31/27

Improve Colorectal Cancer Prevention by Motivational and Community-based Approaches

Phase: N/A Priority: Normal
NCT ID: NCT05568667 Org: User:
Start: 10/17/22 End: 12/06/23 Due: 12/06/24

Perioperative Collection of Temperatures and Hypothermia

Phase: N/A Priority: Normal
NCT ID: NCT04935632 Org: User:
Start: 06/21/21 End: 07/31/22 Due: 07/31/23

Advanced Breast Cancer and Lifestyle Exercise Study

Phase: N/A Priority: Normal
NCT ID: NCT03148886 Org: User:
Start: 10/31/16 End: 01/31/18 Due: 01/31/19

De-escalation Study for Stage IIa/IIb < 3 cm Seminoma

Phase: N/A Priority: Normal
NCT ID: NCT05529251 Org: User:
Start: 09/06/22 End: 09/06/30 Due: 09/06/31

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]

Phase: N/A Priority: Normal
NCT ID: NCT06150040 Org: User:
Start: 09/11/24 End: 02/18/25 Due: 02/18/26